logo
Plus   Neg
Share
Email

Biogen Idec Inc. (BIIB) Fell To A 6-Week Low After Downgrade

Biogen Idec Inc. (BIIB) gapped open sharply lower Wednesday, following a downgrade by Citigroup to "Neutral" from "Buy." The stock declined for the majority of the morning and finished down by 16.48 at $206.55 on strong volume.

Biogen Idec dropped to a month and a half low and fell below its 50-day moving average.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Before the bell

Follow RTT